SCHEMBL3785704

SCHEMBL3785704

Clc1cc(Sc2ccccc2)cc(Sc2ccccc2)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRNA7 P36544 1/20 0.46
PDE7A Q13946 2/20 0.42
PDE7B Q9NP56 1/20 0.42
MAOA P21397 3/20 0.41
MAOB P27338 3/20 0.41
TSHR P16473 1/20 0.41
MAPT P10636 2/20 0.41
POLB P06746 1/20 0.41
TP53 P04637 1/20 0.41
HTR2C P28335 2/20 0.39
HTR6 P50406 2/20 0.39
HPGD P15428 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
MGLL Q99685 1/20 0.39
HSD17B10 Q99714 1/20 0.39
ALDH1A1 P00352 2/20 0.39
LMNA P02545 1/20 0.38
ATM Q13315 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28423177 0.95 CHRNA7 (0.46) CHRNA7PDE7APDE7BMAOAMAOB
SCHEMBL6947110 0.87 MAOA (0.50) CHRNA7MAOAMAOBTSHRMAPT
SCHEMBL7195046 0.86 POLB (0.54) CHRNA7PDE7APDE7BMAOAMAOB
SCHEMBL1958579 0.85 POLB (0.44) MAOAMAOBTSHRPOLBHTR2C
SCHEMBL29215117 0.85 CHRNA7 (0.40) CHRNA7PDE7APDE7BMAOAMAOB
SCHEMBL3786871 0.85 CYP3A4 (0.46) CHRNA7PDE7APDE7BMAOAMAOB
SCHEMBL3282084 0.83 POLB (0.56) CHRNA7PDE7APDE7BMAOAMAOB
SCHEMBL1960937 0.81 TSHR (0.47) CHRNA7PDE7AMAOAMAOBTSHR
SCHEMBL24623383 0.80 CHRNA7 (0.37) CHRNA7PDE7APDE7BMAOAMAOB
SCHEMBL18561707 0.79 CHRNA7 (0.64) CHRNA7PDE7APDE7BMAOAMAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100087680-A1 METHOD FOR PRODUCING BIARYL COMPOUND SUMITOMO CHEMICAL COMPANY LIMITED (JP) 2010-04-08 US disclosed
EP-1914221-A1 PROCESS FOR PRODUCING BIARYL COMPOUND Sumitomo Chemical Company, Limited (JP) 2008-04-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100087680-A1 METHOD FOR PRODUCING BIARYL COMPOUND NISCH, BLVRB, BBOX1 CHRNA7 3342/4885PDE7A 2371/4885PDE7B 3001/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.